For a Harvard-qualified medical doctor with above 30 years in drugs—which include a long time treating cancer patients just before transitioning to integrative drugs—I uncover myself in a novel placement. I realize the biohacking enthusiasm, but I also regard the arduous skepticism of oncology.For t